TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

TRIHEXYPHENIDYL HYDROCHLORIDE

TRIHEXYPHENIDYL HYDROCHLORIDE
Neurology Approved 1974-11-26
10
Indications
--
Phase 3 Trials
51
Years on Market

Details

Status
Prescription
First Approved
1974-11-26
Routes
ORAL
Dosage Forms
TABLET, ELIXIR

TRIHEXYPHENIDYL HYDROCHLORIDE Approval History

Loading approval history...

What TRIHEXYPHENIDYL HYDROCHLORIDE Treats

1 indications

TRIHEXYPHENIDYL HYDROCHLORIDE is approved for 1 conditions since its original approval in 1974. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Parkinsonism
Source: FDA Label
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TRIHEXYPHENIDYL HYDROCHLORIDE FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Trihexyphenidyl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.